diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with diabetes or impaired glucose tolerance 2) HbA1C 5.2~7.0% (JDS) 3)Patients whose content is obtained in written form
Exclusion criteria
Exclusion criteria: 1) Patients with malignant hypertension or secondary hypertension 2) Diabetic patients requiring insulin therapy 3) Pregnant and probably pregnant patients 4) patients with abnormal serum creatinin value 5) Patients with severe hepatic dysfunction 6) Patients who had myocardial infarction or apoplexy within 3 months before the satrt of the study or who are treated. 7) Patients with severe allergy or with steroid therapy 8) Patients with pancreatitis or pasthistory of pancreatitis 9) Patients with malignacy 10) Other patients judged as being inappropriate for the subjects of the study by investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Following items at every 3 months 1 changes in plasma glucose level and HbA1C 2 Changes in urine alubumin excretion 3 Changes in lipid levels 4 Changes in blood pressure 5 Changes in body weight and body mass index(BMI) 6 Occurrence of diabetic complication 7 Newly required medicine for diabetes, blood pressure, or dyslipidemia | — |
Countries
Japan
Contacts
Kanazawa University Kanazawa University Hospital